Table 2.
Incidence of MACCE in low and high TyG index group.
| Endpoint event | Total population | Low TyG index group | High TyG index group | P value |
|---|---|---|---|---|
| (n=1650) | (n=825) | (n=825) | ||
| MACCE, n (%) | 437(26.5%) | 187(22.7%) | 250(30.3%) | < 0.001 |
| All-cause death, n (%) | 77(4.7%) | 31(3.8%) | 46(5.6%) | 0.080 |
| Cardiac death, n (%) | 52(3.2%) | 19(2.3%) | 33(4.0%) | 0.047 |
| Non-fatal MI, n (%) | 10(0.6%) | 2(0.2%) | 8(1.0%) | 0.057 |
| Non-fatal ischemic stroke, n (%) | 21(1.3%) | 8(1.0%) | 13(1.6%) | 0.272 |
| Ischemia-driven revacularization, n (%) | 77(4.7%) | 30(3.6%) | 47(5.7%) | 0.046 |
| Cardiac rehospitalization, n (%) | 252(15.3%) | 116(14.1%) | 136(16.5%) | 0.171 |
MACCE, major adverse cardiovascular and cerebrovascular events; TyG, triglyceride-glucose; MI, myocardial infarction.